Renaissance Technologies (RenTech)'s ICUI Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 11,309 shares of ICU Medical, Inc. (ICUI) worth $1.46 M, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 48 quarters.
Based on 13F filings since 2013, Renaissance Technologies (RenTech) has maintained a long-term strategic position in ICUI, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2013, adding 203,900 shares. Largest reduction occurred in Q3 2017, reducing 145,300 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s ICU Medical (ICUI) Holding Value Over Time
Track share changes against reported price movement
Quarterly ICU Medical (ICUI) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -24,991 | Reduce 68.85% | 11,309 | $129.15 |
| Q4 2025 | -33,100 | Reduce 47.69% | 36,300 | $142.67 |
| Q3 2025 | -17,200 | Reduce 19.86% | 69,400 | $119.96 |
| Q2 2025 | +77,800 | Add 884.09% | 86,600 | $132.15 |
| Q1 2025 | +8,800 | New Buy | 8,800 | $138.86 |
| Q3 2024 | -10,000 | Sold Out | 0 | $0.00 |
| Q2 2024 | +10,000 | New Buy | 10,000 | $118.75 |
| Q3 2023 | -86,000 | Sold Out | 0 | $0.00 |
| Q2 2023 | +58,600 | Add 213.87% | 86,000 | $0.18 |
| Q1 2023 | +18,800 | Add 218.60% | 27,400 | $0.16 |
| Q4 2022 | -38,600 | Reduce 81.78% | 8,600 | $0.16 |
| Q3 2022 | -35,300 | Reduce 42.79% | 47,200 | $150.59 |
| Q2 2022 | +17,900 | Add 27.71% | 82,500 | $164.39 |
| Q1 2022 | -10,400 | Reduce 13.87% | 64,600 | $222.65 |
| Q4 2021 | -17,400 | Reduce 18.83% | 75,000 | $237.35 |
| Q3 2021 | +37,100 | Add 67.09% | 92,400 | $233.38 |
| Q2 2021 | +23,300 | Add 72.81% | 55,300 | $205.80 |
| Q1 2021 | +13,200 | Add 70.21% | 32,000 | $205.44 |
| Q4 2020 | -25,000 | Reduce 57.08% | 18,800 | $214.47 |
| Q3 2020 | +31,000 | Add 242.19% | 43,800 | $182.76 |
| Q2 2020 | +10,400 | Add 433.33% | 12,800 | $184.30 |
| Q1 2020 | +2,400 | New Buy | 2,400 | $201.67 |
| Q3 2019 | -9,100 | Sold Out | 0 | $0.00 |
| Q2 2019 | +9,100 | New Buy | 9,100 | $251.87 |
| Q1 2019 | -76,300 | Sold Out | 0 | $0.00 |
| Q4 2018 | -132,789 | Reduce 63.51% | 76,300 | $229.63 |
| Q3 2018 | -103,411 | Reduce 33.09% | 209,089 | $282.75 |
| Q2 2018 | +3,400 | Add 1.10% | 312,500 | $293.65 |
| Q1 2018 | -23,600 | Reduce 7.09% | 309,100 | $252.40 |
| Q4 2017 | -110,300 | Reduce 24.90% | 332,700 | $216.00 |
| Q3 2017 | -145,300 | Reduce 24.70% | 443,000 | $185.85 |
| Q2 2017 | -108,549 | Reduce 15.58% | 588,300 | $172.50 |
| Q1 2017 | -42,851 | Reduce 5.79% | 696,849 | $152.70 |
| Q4 2016 | +700 | Add 0.09% | 739,700 | $147.35 |
| Q3 2016 | -54,100 | Reduce 6.82% | 739,000 | $126.38 |
| Q2 2016 | -48,900 | Reduce 5.81% | 793,100 | $112.75 |
| Q1 2016 | +29,200 | Add 3.59% | 842,000 | $104.10 |
| Q4 2015 | +50,200 | Add 6.58% | 812,800 | $112.78 |
| Q3 2015 | +73,866 | Add 10.72% | 762,600 | $109.50 |
| Q2 2015 | +79,034 | Add 12.96% | 688,734 | $95.66 |
| Q1 2015 | +64,959 | Add 11.92% | 609,700 | $93.14 |
| Q4 2014 | -13,159 | Reduce 2.36% | 544,741 | $81.90 |
| Q3 2014 | -87,600 | Reduce 13.57% | 557,900 | $64.18 |
| Q2 2014 | -86,701 | Reduce 11.84% | 645,500 | $60.81 |
| Q1 2014 | +133,701 | Add 22.34% | 732,201 | $59.88 |
| Q4 2013 | +203,900 | Add 51.67% | 598,500 | $63.71 |
| Q3 2013 | +141,000 | Add 55.60% | 394,600 | $67.93 |
| Q2 2013 | +253,600 | Add 0.00% | 253,600 | $72.06 |
Renaissance Technologies (RenTech)'s ICU Medical Investment FAQs
Renaissance Technologies (RenTech) first purchased ICU Medical, Inc. (ICUI) in Q2 2013, acquiring 253,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held ICU Medical, Inc. (ICUI) for 48 quarters since Q2 2013.
Renaissance Technologies (RenTech)'s largest addition to ICU Medical, Inc. (ICUI) was in Q2 2013, adding 253,600 shares worth $18.27 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 11,309 shares of ICU Medical, Inc. (ICUI), valued at approximately $1.46 M.
As of the Q1 2026 filing, ICU Medical, Inc. (ICUI) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in ICU Medical, Inc. (ICUI) was 842,000 shares, as reported at the end of Q1 2016.